First Identification of the New Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant (B.1.1.529) in Italy

被引：12
|
作者：
Micheli, Valeria [1 ]
Bracchitta, Fiorenza [1 ]
Rizzo, Alberto [1 ]
Mancon, Alessandro [1 ]
Mileto, Davide [1 ]
Lombardi, Alessandra [1 ]
Stefanelli, Paola [2 ]
Gismondo, Maria Rita [1 ]
机构：
[1] ASST Fatebenefratelli Sacco, Lab Clin Microbiol Virol & Bioemergencies, 74 Via Gian Battista Grassi, I-20157 Milan, Italy
[2] Ist Super Sanita, Dept Infect Dis, Rome, Italy
来源：
CLINICAL INFECTIOUS DISEASES | 2022年 / 75卷 / 03期
关键词：
SARS-CoV-2; viral variants; Omicron; B; 1; 529; COVID-19;
D O I：
10.1093/cid/ciab1044
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
We identified the first case in Italy of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) B.1.1.529 variant, using whole-genome sequencing in an Italian subject traveling from Mozambique. Specific mutation profiles deserve further investigations to clarify potential effects on vaccination efficacy. This case highlights the crucial role of rapid and continuous surveillance of SARS-CoV-2 variant circulation.
引用
收藏
页码：522 / 524
页数：3
相关论文
共 50 条
  • [1] Two Cases of Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infections Caused by the Omicron Variant (B.1.1.529 Lineage) in International Travelers to Japan
    Maruki, Taketomo
    Iwamoto, Noriko
    Kanda, Kohei
    Okumura, Nobumasa
    Yamada, Gen
    Ishikane, Masahiro
    Ujiie, Mugen
    Saito, Masumichi
    Fujimoto, Tsuguto
    Kageyama, Tsutomu
    Saito, Tomoya
    Saito, Shinji
    Suzuki, Tadaki
    Ohmagari, Norio
    CLINICAL INFECTIOUS DISEASES, 2022, 75 (01) : E354 - E356
  • [2] First detection of SARS-CoV-2 variant B.1.1.529 (Omicron) in Ecuador
    Carrazco-Montalvo, A.
    Armendariz-Castillo, I.
    Tello, C. L.
    Morales, D.
    Armas-Gonzalez, R.
    Guizado-Herrera, D.
    Leon-Sosa, A.
    Ramos-Sarmiento, D.
    Fuertes, B.
    Cardenas, P.
    Marquez, S.
    Prado-Vivar, B.
    Guadalupe, J. J.
    Gutierrez, B.
    Grunauer, M.
    Trueba, G.
    Rojas-Silva, P.
    Patino, V. Barragan L.
    NEW MICROBES AND NEW INFECTIONS, 2022, 45
  • [3] SARS-CoV-2 Omicron (B.1.1.529) Variant: Corticosteroids Treatment/Respiratory Coinfection
    Elkoshi, Zeev
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [4] Rapid Emergence of the Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2 in Korea
    Park, Ae Kyung
    Kim, Il-Hwan
    Lee, Chae Young
    Kim, Jeong-Ah
    Lee, Hyeokjin
    Kim, Heui Man
    Lee, Nam-Joo
    Woo, SangHee
    Lee, Jaehee
    Rhee, JeeEun
    Yoo, Cheon-Kwon
    Kim, Eun-Jin
    ANNALS OF LABORATORY MEDICINE, 2023, 43 (02) : 211 - 213
  • [5] Seizure in children with severe acute respiratory syndrome coronavirus 2 Omicron variant infection
    Iio, Kazuki
    Hagiwara, Yusuke
    Saito, Osamu
    Ishida, Yu
    Horikoshi, Yuho
    PEDIATRICS INTERNATIONAL, 2022, 64 (01)
  • [6] The updated strategy to overcome new challenge: Omicron variant (B.1.1.529) pandemic
    Ri, HyokJu
    Chen, Xin
    CLINICAL AND TRANSLATIONAL DISCOVERY, 2022, 2 (01):
  • [7] Emerging evidence on Omicron (B.1.1.529) SARS-CoV-2 variant
    Sharma, Vineet
    Rai, Himanshu
    Gautam, Dev N. S.
    Prajapati, Pradeep K.
    Sharma, Rohit
    JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (05) : 1876 - 1885
  • [8] Omicron variant (B.1.1.529) of SARS-CoV-2: Threat for the elderly?
    Chavda, Vivek P.
    Apostolopoulos, Vasso
    MATURITAS, 2022, 158 : 78 - 81
  • [9] An evolutionary insight into Severe Acute Respiratory Syndrome Coronavirus 2 Omicron variant of concern.
    Paz, Mercedes
    Aldunate, Fabian
    Arce, Rodrigo
    Ferreiro, Irene
    Cristina, Juan
    VIRUS RESEARCH, 2022, 314
  • [10] Effectiveness of first-generation severe acute respiratory syndrome coronavirus 2 mRNA vaccines against the Omicron variant
    Dagan, Noa
    Barda, Noam
    CLINICAL MICROBIOLOGY AND INFECTION, 2022, 28 (12) : 1526 - 1527
12345